Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis

Journal of Neuroimmunology

Volumn 203, Issue 1, 2008, Pages 104-107

  Ramagopalan, Sreeram V ^a,b   Cukjati, Marko ^c   Černilec, Maja ^c   DeLuca, Gabriele C ^a,b   Dyment, David A ^a,b   Degenhardt, Alexandra ^a   Sadovnick, A Dessa ^d   Šerbec, Vladka Čurin ^c   Ebers, George C ^a,b   Duquette, Pierre ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^d Div Neurol Dept Pediat U   (Canada)

^e NOTRE DAME HOSPITAL   (Canada)

Author keywords

Genetics; HFE; Iron; Multiple sclerosis; Outcome

Indexed keywords

HFE PROTEIN;

ADULT; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; POINT MUTATION; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 52949104025     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.06.036     Document Type: Article

References (26)

1. Aguilar-Martinez P., Bismuth M., Picot M.C., Thelcide C., Pageaux G.P., Blanc F., Blanc P., Schved J.F., and Larrey D. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?. Gut. 48 (2001) 836-842
2. Bermel R.A., Puli S.R., Rudick R.A., Weinstock-Guttman B., Fisher E., Munschauer III F.E., and Bakshi R. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch. Neurol. 62 (2005) 1371-1376
3. Brassat D., Azais-Vuillemin C., Yaouanq J., Semana G., Reboul J., Cournu I., Mertens C., Edan G., Lyon-Caen O., Clanet M., and Fontaine B. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurol. 52 (1999) 1632-1636
4. Chataway J., Mander A., Robertson N., Sawcer S., Deans J., Fraser M., Broadley S., Clayton D., and Compston A. Multiple sclerosis in sibling pairs: an analysis of 250 families. J. Neurol. Neurosurg. Psychiatry 71 (2001) 757-761
5. Cukjati M., Vaupotic T., Rupreht R., and Curin-Serbec V. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay. BMC Med. Genet. 8 (2007) 69
6. DeLuca G.C., Ramagopalan S.V., Herrera B.M., Dyment D.A., Lincoln M.R., Montpetit A., Pugliatti M., Barnardo M.C., Risch N.J., Sadovnick A.D., Chao M., Sotgiu S., Hudson T.J., and Ebers G.C. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Natl. Acad. Sci. U S A. 104 (2007) 20896-20901
7. Ebers G.C. Natural history of primary progressive multiple sclerosis. Mult. Scler. 1 10 Suppl (2004) S8-13 discussion S13-15
8. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo Jr. R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Prass C.E., Quintana L., Starnes S.M., Schatzman R.C., Brunke K.J., Drayna D.T., Risch N.J., Bacon B.R., and Wolff R.K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996) 399-408
9. Gochee P.A., Powell L.W., Cullen D.J., Du Sart D., Rossi E., and Olynyk J.K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterol. 122 (2002) 646-651
10. Grant S.M., Wiesinger J.A., Beard J.L., and Cantorna M.T. Iron-deficient mice fail to develop autoimmune encephalomyelitis. J. Nutr. 133 (2003) 2635-2638
11. Hensiek A.E., Seaman S.R., Barcellos L.F., Oturai A., Eraksoi M., Cocco E., Vecsei L., Stewart G., Dubois B., Bellman-Strobl J., Leone M., Andersen O., Bencsik K., Booth D., Celius E.G., Harbo H.F., Hauser S.L., Heard R., Hillert J., Myhr K.M., Marrosu M.G., Oksenberg J.R., Rajda C., Sawcer S.J., Sorensen P.S., Zipp F., and Compston D.A. Familial effects on the clinical course of multiple sclerosis. Neurol. 68 (2007) 376-383
12. Jackson H.A., Carter K., Darke C., Guttridge M.G., Ravine D., Hutton R.D., Napier J.A., and Worwood M. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br. J. Haematol. 114 (2001) 474-484
13. Kantarci O.H., de Andrade M., and Weinshenker B.G. Identifying disease modifying genes in multiple sclerosis. J. Neuroimmunol. 123 (2002) 144-159
14. Mura C., Raguenes O., and Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93 (1999) 2502-2505
15. Nebert D.W. Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics. Eur. J. Pharmacol. 410 (2000) 107-120
16. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
17. Ramagopalan S.V., Dyment D.A., Valdar W., Herrera B.M., Criscuoli M., Yee I.M., Sadovnick A.D., and Ebers G.C. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol. 6 (2007) 604-610
18. Risch N., and Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Sci. 268 (1995) 1584-1589
19. Ristic S., Lovrecic L., Brajenovic-Milic B., Starcevic-Cizmarevic N., Jazbec S.S., Sepcic J., Kapovic M., and Peterlin B. Mutations in the hemochromatosis gene (HFE) and multiple sclerosis. Neurosci. Lett. 383 (2005) 301-304
20. Robertson N.P., Clayton D., Fraser M., Deans J., and Compston D.A. Clinical concordance in sibling pairs with multiple sclerosis. Neurol. 47 (1996) 347-352
21. Rubio J.P., Bahlo M., Tubridy N., Stankovich J., Burfoot R., Butzkueven H., Chapman C., Johnson L., Marriott M., Mraz G., Tait B., Wilkinson C., Taylor B., Speed T.P., Foote S.J., and Kilpatrick T.J. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum. Genet. 114 (2004) 573-580
22. Sadovnick A.D., Risch N.J., and Ebers G.C. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can. J. Neurol. Sci. 25 (1998) 216-221
23. Sfagos C., Makis A.C., Chaidos A., Hatzimichael E.C., Dalamaga A., Kosma K., and Bourantas K.L. Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients. Mult. Scler. 11 (2005) 272-275
24. Valberg L.S., Flanagan P.R., Kertesz A., and Ebers G.C. Abnormalities in iron metabolism in multiple sclerosis. Can. J. Neurol. Sci. 16 (1989) 184-186
25. Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D., and Ebers G.C. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl. Acad. Sci. U S A. 100 (2003) 12877-12882
26. Yu G.S., Steinkirchner T.M., Rao G.A., and Larkin E.C. Effect of prenatal iron deficiency on myelination in rat pups. Am. J. Pathol. 125 (1986) 620-624